ALTURiX are pleased to announce the launch of DEMOVO® Desmopressin 360mcg/ml oral solution.
An additional option for the treatment of both nocturnal enuresis and diabetes insipidus is now available in the UK.
DEMOVO® is a concentrated Desmopressin oral solution containing 360mcg of Desmopressin per millilitre and is indicated for the treatment of central diabetes insipidus, and the treatment of primary nocturnal enuresis in patients (over 5 years of age) with normal ability to concentrate urine
Further information can be found here.
